Lifegate Pharma to foray into big cities like Mumbai, Delhi, Chennai, Kochi & Hyderabad
Lifegate Pharmaceuticals Pvt. Ltd. a pharmaceutical company specializing in safety products, ambulance consumables and medicines, is planning to tap into the Tier II & III markets and will add 20 Indian cities to the portfolio, which includes Mumbai, Delhi, Chennai, Kochi, Hyderabad and Karnataka
Logistics & Distribution | 11/10/2021 | By Darshana | 353
Dr Reddy's launches Reddy-Lenalidomide in Canada
Dr Reddy's Laboratories yesterday launched Reddy-Lenalidomide, a generic equivalent to Revlimid (lenalidomide) capsules in the Canadian market. The product is approved by Health Canada, the company notified in a statement
Logistics & Distribution | 04/09/2021 | By Darshana | 290
NMPB launches national campaign to promote cultivation of medicinal plants
The National Medicinal Plants Board (NMPB), under the Union Ministry of Ayush, has launched a national campaign to promote cultivation of medicinal plants in the country as part of the Azadi Ka Amrit Mahotsav. This will help in increasing the income of farmers and realize the dream of Green India
Logistics & Distribution | 03/09/2021 | By Darshana | 714
Azerbaijan offers lucrative opportunities for Indian drug exporters
Instructions on the packaging on the drugs in Azerbaijan are allowed to be in four languages -- Russian, English, Turkish and Azerbaijani which create an opportunity to sell drugs intended for the Russian and European market in Azerbaijan, said Uday Bhaskar, director general, Pharmexcil
Logistics & Distribution | 02/09/2021 | By Darshana | 459
Abbott, the global healthcare company has announced the introduction of a room-temperature-stable, single-dose formulation of carbetocin in India, which is available in convenient vials, to help in the prevention of postpartum haemorrhage (PPH). Abbott's product is available in the private sector
Logistics & Distribution | 31/08/2021 | By Darshana | 354
CDSCO issues pathway for regularisation of 19 FDCs out of 294 which require further data
The Central Drugs Standard Control Organisation (CDSCO) has issued a pathway for regularisation of 19 fixed dose combinations (FDCs) out of the 294 FDCs which require further generation of data and were licensed by State Licensing Authority (SLA) without prior approval from the Drugs Controller General (India)
Logistics & Distribution | 30/08/2021 | By Darshana | 368
CDSCO declares 44 drug samples as not of standard, one as misbranded in July
The Central Drugs Standard Control Organisation (CDSCO) has declared 44 drug samples out of 1028 it has tested as not of standard quality, during the month of July, 2021. Of the samples tested, 983 were declared as of standard quality
Logistics & Distribution | 23/08/2021 | By Darshana | 487
The Drugs Controller General (India) has classified 135 medical devices related to ophthalmology under the provisions of Medical Devices Rules, 2017. In another notice, it has also classified 51 medical devices pertaining to respiratory treatments under the provisions of Medical Devices Rules
Logistics & Distribution | 11/08/2021 | By Darshana | 251
Abbott launches Panbio COVID-19 Antigen Self-Test in India
Abbott has launched Panbio COVID-19 Antigen Self-Test for detecting SARS-CoV-2 virus in adults and children with or without symptoms. In alignment with the current ICMR advisory on self-use, these tests will be made available to ramp up testing of symptomatic and asymptomatic individuals and contacts of confirmed coronavirus cases
Logistics & Distribution | 13/07/2021 | By Darshana | 305
Optima announces new laboratory, scheduling and resource management system
Optima's algorithm combines all information collected in the system setting and the historical data generated, to provide a scheduling proposal on the best way to coordinate the human and instruments resources to execute the tasks requested and respond to the laboratory's demand.
Logistics & Distribution | 01/07/2021 | By Darshana | 252
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy